Aralast alpha1-proteinase Inhibitor Surveillance Study

NCT00313144 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

127

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated early due to Aralast being phased out of the market.

Conditions

Alpha1-antitrypsin Deficiency

Interventions

DRUG: ARALAST Alpha1-Proteinase Inhibitor

Sponsor

Baxalta now part of Shire